..read more

..read more

PHC Corporation Biomedical Division (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura, hereinafter referred to as "Biomedical Division") will showcase a prototype of its new cell expansion system LiCellGrow at the ISCT (International Society for Cell & Gene Therapy) Europe 2024 Regional Meeting held in Gothenburg, Sweden on September 4-6 ..read more

Joyce University offers two post-licensure programs for those looking to further their nursing careers: the 4-semester online RN to BSN program and the 3-semester online MSN in Leadership program ..read more

By leveraging its ultra-intensified fed-batch platform, WuXiUI™, WuXi Biologics has completed its first scale-up to 2,000L drug substance (DS) GMP manufacturing, achieving a 4-fold productivity improvement compared to the traditional fed-batch process. The competitive performance achieved through the utilization of both WuXiUI™ and the proprietary platform cell culture media MagniCHO™ led to significant reduction in overall DS manufacturing COGS The consistent performance of WuXiUI™ – from small scales to 2,000L GMP manufacturing – is a testament to the advancement of the technology as a matur ..read more

Envoy Medical has taken a different approach with its fully implanted hearing devices, and it looks to turn the industry on its… ear. "Listen" to what Brent Lucas, CEO of the company has to say ..read more

Anavex Life Sciences focuses on better understanding cognitive aging, superagers and how disease pathologies relate to cognitive aging ..read more

The results further showed that while their overall risk remained small, kidney donors who were male and those with a history of high blood pressure were more likely to die within 90 days of surgery than other donors. Meanwhile, age, race, and ethnicity had no bearing on mortality ..read more

“Dr. Abhisek Swaika is deeply committed to ensuring the delivery of the highest quality, state-of-the art cancer care,” said Richard Carvajal, MD, deputy physician-in-chief and director of medical oncology at Northwell Health Cancer Institute. “His leadership and experience will continue to drive our mission to care for the diverse patient population we have the privilege to see at our cancer center in Queens ..read more

The 30-patient study reported that the Delcath Systems HEPZATO KIT™ (melphalan/Hepatic Delivery System (HDS)) provided better disease control in the liver and improved progression-free survival in patients with hepatic metastases from uveal melanoma, compared to both immunotherapy and other liver-directed therapies ..read more